| Title |
Medulloblastoma oncogene aberrations are not involved in tumor initiation, but essential for disease progression and therapy resistance
|
|---|---|
| Published in |
bioRxiv, February 2024
|
| DOI | 10.1101/2024.02.09.579690 |
| Authors |
Konstantin Okonechnikov, Piyush Joshi, Verena Körber, Anne Rademacher, Michele Bortolomeazzi, Jan-Philipp Mallm, Patricia Benites Goncalves da Silva, Britta Statz, Mari Sepp, Ioannis Sarropoulos, Tetsuya Yamada-Saito, Jan Vaillant, Andrea Wittmann, Kathrin Schramm, Mirjam Blattner-Johnson, Petra Fiesel, Barbara Jones, Till Milde, Kristian Pajtler, Cornelis M. van Tilburg, Olaf Witt, Konrad Bochennek, Katharina Johanna Weber, Lisa Nonnenmacher, Christian Reimann, Ulrich Schüller, Martin Mynarek, Stefan Rutkowski, David T.W. Jones, Andrey Korshunov, Karsten Rippe, Frank Westermann, Supat Thongjuea, Thomas Höfer, Henrik Kaessmann, Lena M. Kutscher, Stefan M. Pfister |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 5 | 36% |
| United States | 2 | 14% |
| Australia | 1 | 7% |
| United Kingdom | 1 | 7% |
| Unknown | 5 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 57% |
| Scientists | 6 | 43% |